News Image

IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction

Provided By PR Newswire

Last update: Nov 10, 2025

Mr. Levav's appointment ensures seamless and focused organizational structure as Company expands commercial activities in the U.S. following FDA marketing clearance for ProSense®

Read more at prnewswire.com

ICECURE MEDICAL LTD

NASDAQ:ICCM (11/20/2025, 8:00:01 PM)

After market: 0.6462 0 (-0.43%)

0.649

-0.05 (-7.23%)



Find more stocks in the Stock Screener

ICCM Latest News and Analysis

Follow ChartMill for more